Pain relief showdown: ketamine vs fentanyl for gallbladder surgery
NCT ID NCT07670052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs, ketamine and fentanyl, added to a standard numbing medicine (bupivacaine) to control pain after laparoscopic gallbladder removal. 84 adults aged 20-50 will receive one of the two combinations during surgery. The goal is to see which provides longer-lasting pain relief and reduces the need for additional painkillers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ketamine and fentanyl (as adjuvants to bupivacaine)
- What this could lead to
- If it works, this could point toward a better way to manage pain after gallbladder surgery, reducing the need for strong painkillers.
- What could go wrong
- This is a small, early-phase trial (84 people) comparing two common drugs, so any benefit may be modest or not apply to everyone. Risks include side effects from the drugs themselves.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients of age 20-50 years * Patients of either gender * Patients planned to undergo elective LC. * Patients have I-II of the American Society of Anaesthesiologists (ASA) Exclusion Criteria: * Patient's refusal. * body mass index (BMI) ≥40 kg/m2. * History of hypersensitivity to the drugs being evaluated * Inability to comprehend postoperatively the pain assessment scale/neuropsychiatric disorders. * chronic use of opioids and opioid addiction * Patients with acute cholecystitis or converted to open surgery. * Carcinoma of gall bladder * Pregnant female * Bleeding disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gallbladder stones are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two nerve blocks go head to head for chest surgery pain
- Can a Nurse's confidence ease a Patient's postoperative pain?
- Antidepressant may double as pain reliever after gallbladder surgery
- Nerve blocks put to the test for breast surgery pain
- A Non-Opioid pain drug takes aim at Surgery's opioid problem
- Can a nerve block stop pain months after hysterectomy?